Keeping Track: Approval Of First Intranasal Naloxone Copycat Highlights Otherwise Generic Week
Executive SummaryThe latest drug development news and highlights from our US FDA Performance Tracker.
You may also be interested in...
Purdue proposes continuing the development of nalmefene hydrochloride and other products under a new company that would provide the products at no or low cost.
The latest drug development news and highlights from our US FDA Performance Tracker.
In announcing expedited assessments for new naloxone ANDAs, the agency also offers guidance to sponsors of discontinued products considering a return to marketing.